February #56 : Easy as C&E - by Lark Lands

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

HIV: Behind The Music

A Star Is Torn

Free Your Mind

Everyday Grace


Marriage Vows

House of Trials

In The Works


Shout Out

Getting Testy

Love Me

Shout Out

The Times, They Are a Changin’

Say What?

Catching Up With?

Never A Dull Momentum

All Aboard The Love Boat


Special Ed

Of Dykes & Data

Dead on Approval

Take the Cake

Dances With Woolf

Sweet Chariot

Heart Beat

Hitting Below The Belt

She’s A Big Girl Now

To Good To Be The Flu

Herb Of The Month

Prevention Suspension

Comfort Zone

Easy as C&E

Shelf Life

2.07.84: Eureka!

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

February 2000

Easy as C&E

by Lark Lands

Could popping a few vitamins reduce the miserable side effects of the standard therapy for hepatitis C virus (HCV)? The promising results of a recent study could spell good news for those considering taking an interferon/ribavirin combo (marketed together as Rebetron or available generically). Interferon has long been notorious for sparking flu-from-hell symptoms; since Rebetron’s approval, HCVers now also face the risk of ribavirin-induced anemia. This condition can not only force a dose reduction that may compromise effectiveness, but “patients often feel short of breath, become weaker and are unable to do their normal workload,” notes Edward Piken, MD, research director at South Bay Gastroenterology in Torrance, California.

Theorizing that ribavirin’s buildup in red blood cells causes oxidative stress and early cell death, Piken’s group studied whether antioxidants might prevent the anemia. They added vitamins C (1,000 milligrams daily) and E (800 international units daily) to Rebetron in 12 previously untreated HCV patients. “We chose these antioxidants because they have essentially no side effects, and many people already take them,” Piken says. Throughout the six months of treatment, those on antioxidants had a milder, slower-developing anemia than did the 14 patients in the Rebetron-only control group—which meant that the nutrient takers could do without the ribavirin dose reductions needed by a quarter of the control group. Piken is now participating in a larger study using a more potent form of vitamin E.

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.